BMO Capital Upgrades Onyx Pharmaceuticals (ONXX) to Outperform
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $93.03 +0.13%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade ONXX Now!
BMO Capital upgraded Onyx Pharmaceuticals (NASDAQ: ONXX) from Market Perform to Outperform, price target raised from $34 to $48.
For more ratings news on Onyx Pharmaceuticals click here and for the rating history of Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $34.49 yesterday, with a 52 week range of $25.78-$45.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Onyx Pharmaceuticals click here and for the rating history of Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $34.49 yesterday, with a 52 week range of $25.78-$45.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Brean Capital Raises Onyx (ONXX) Price Target to $115
- Compuware (CPWR) Estimates Trimmed, PT Raised at Jefferies
- Sterne Agee Upgrades Cree (CREE) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
BMO Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
